The role of proteinases from Pseudomonas aeruginosa and polymorphonuclear leukocytes in cystic fibrosis

Drugs of Today

Volumn 33, Issue 6, 1997, Pages 393-403

  Döring, Gerd ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; PROTEINASE INHIBITOR;

CYSTIC FIBROSIS; ENZYME ACTIVITY; HUMAN; LEUKOCYTE; POLYMORPHONUCLEAR CELL; PSEUDOMONAS AERUGINOSA; REVIEW;

EID: 0345550727     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Hodson, M.E., Geddes, D. (Eds.). Cystic Fibrosis. Chapman and Hall: London 1995, 99-130.
2. Cystic Fibrosis Foundation. Patient Registry 1994 Annual Data Report. Bethesda: Maryland, August 1995.
3. Döring, G., Holder, I.A., Botzenhart, K. (Eds.). Basic Research and Clinical Aspects of Pseudomonas aeruginosa. Karger: Basel 1987.
4. Høiby, N., Pedersen, S.S., Shand, S.J., Döring, G., Holder, I.A. (Eds.). Pseudomonas aeruginosa Infection. Karger: Basel 1989.
5. Homma, J.Y., Tanimoto, H., Holder, I.A., Høiby, N., Döring, G. (Eds.). Basic Research and Clinical Aspects of Pseudomonas aeruginosa Infection. Karger: Basel 1991.
6. Bevilacqua, M.P. Endothelial-leukocyte adhesion molecules. Ann Rev Immunol 1993, 62: 767-805.
7. Kharazmi, A., Schiøtz, P.O., Hoiby, N., Baek, L., Döring, G. Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest 1986, 16: 143-8.
8. Fick, R.B. Jr., Robbins, R.A., Squier, S.U., Schoderbek, W.E., Russ, W.D. Complement activation in cystic fibrosis respiratory fluids: In vivo and in vitro generation of C5a and chemotactic activity. Pediatr Res 1986, 20: 1258-68.
9. Cromwell, O., Walport, M.J., Morris, H.R. et al. Identification of leukotrienes D and B in sputum from cystic fibrosis patients. Lancet 1981, i, 164-5.
10. Zakrzewski, J.T., Barnes, N.C., Costello, J.F., Piper, P.J. Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease. Am Rev Respir Dis 1987, 136: 779-82.
11. 4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 1989, 84: 1609-19.
12. Khan, T.Z., Wagener, J.S., Bost, T., Martinez, J., Accurso, F.J., Riches, D.W.H. Early pulmonary inflammation in infants with cystic fibrosis. Am J Crit Care Med 1995, 151: 1075-82.
13. Savill, J.S., Wyllie, A.H., Henson, J.E., Walport, M.J., Henson, P.M., Haslett, C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989, 83: 865-75.
14. Goldstein, I.M. Polymorphonuclear leukocyte lysosomes and tissue injury. Prog Allergy 1976, 20: 301-40.
15. Sandborg, R.R., Smolen, J.E. Biology of disease. Early biochemical events in leukocyte activation. Lab Invest 1988, 59: 300-20.
16. Bever, R.A., Iglewski, B.H. Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene. J Bacteriol 1988, 170: 4309-14.
17. Fukushima, J., Yamamoto, S., Morihara, K. et al. Structural gene and complete amino acid sequence of Pseudomonas aeruginosa IFO 3455 elastase. J Bacteriol 1989, 171: 1698-704.
18. Guzzo, J., Murgier, M., Filloux, A., Lazdunski, A. Cloning of the Pseudomonas aeruginosa alkaline protease gene and secretion of the protease into the medium by Escherichia coli. J Bacteriol 1990, 172: 942-8.
19. Guzzo, J., Duong, F., Wandersman, C., Murgier, M., Lazdunski, A. The secretion genes of Pseudomonas aeruginosa alkaline protease are functionally related to those of Erwinia chrysanthemi proteases and Escherichia coli α-haemolysin. Mol Microbiol 1991, 5: 447-53.
20. Gustin, J.K., Kessler, E., Ohman, D.E. A substitution at His-120 in the LasA protease of Pseudomonas aeruginosa blocks enzymatic activity without affecting propeptide processing or extracellular secretion. J Bacteriol 1996, 178: 6608-17.
21. Goldberg, J.B., Ohman, D.E. Cloning and transcriptional regulation of the elastase LasA gene in mucoid and nonmucoid Pseudomonas aeruginosa. J Bacteriol 1987, 169: 1349-51.
22. Hase, C.C., Finkelstein, R.A. Cloning and nucleotide sequence of the Vibrio cholerae hemagglutinin/protease (HA/protease) gene and construction of an HA/protease-negative strain. J Bacteriol 1991, 173: 3311-7.
23. Smith, A.W., Chahal, B., French, G.L. The human gastric pathogen Helicobacter pylori has a gene encoding an enzyme first classified as a mucinase in Vibrio cholerae. Mol Microbiol 1994, 13: 153-60.
24. Black, W.J., Quinn, F.D., Tompkins, L.S. Legionella pneumophila zinc metalloprotease is structurally and functionally homologous to Pseudomonas aeruginosa elastase. J Bacteriol 1990, 172: 2608-13.
25. Kawamoto, S., Shibano, Y., Fukushima, J., Ishii, N., Morihara, K., Okuda, K. Site-directed mutagenesis of Glu-141 and His-223 in Pseudomo nas aeruginosa elastase: Catalytic activity, processing, and protective activity of the elastase against Pseudomonas infection. Infect Immun 1993, 61: 1400-5.
26. Thayer, M.M., Flaherty, K.M., McKay, D.B. Three-dimensional structure of the elastase of Pseudomonas aeruginosa at 1.5-Å resolution. J Biol Chem 1991, 266: 2864-71.
27. Baumann, U. Crystal structure of the 50 kDa metalloprotease from Serratia marcescens. J Mol Biol 1994, 242: 244-51.
28. Baumann, U., Wu, S., Flaherty, K.M., McKay, D.B. Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: A two-domain protein with a calcium binding parallel beta roll motif. EMBO J 1993, 12: 3357-64.
29. Kessler, E., Safrin, M., Olson, J.C. Oman, D.E. Secreted LasA of Pseudomonas aeruginosa is a staphylolytic protease. J Biol Chem 1993, 268: 7503-8.
30. Toder, D.S., Gambello, M.J., Iglewski, B.H. Pseudomonas aeruginosa LasA: A second elastase under the transcriptional control of LasR. Mol Microbiol 1991, 5: 2003-10.
31. Gambello, M.J., Kaye, S., Iglewski, B.H. LasR of Pseudomonas aeruginosa is a transcriptional activator of the alkaline protease gene (apr) and an enhancer of exotoxin A expression. Infect Immun 1993, 61: 1180-4.
32. Brint, J.M., Ohman, D.E. Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of Rh1R-Rh1l, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-Luxl family. J Bacteriol 1995, 177: 7155-63.
33. Latifi A., Winson, M.K., Foglino, M. et al. Multiple homologues of LuxR and Luxl control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol Microbiol 1995, 17: 333-43.
34. Stiritz, D.D., Holder, I.A. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: Description of a burned mouse model. J Infect Dis 1975, 131: 688-91.
35. Pavlovskis, O.R., Wretlind, B. Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection. Infect Immun 1979, 24: 181-7.
36. Holder, I.A., Haidaris, C.G. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: Extracellular protease and elastase as in vivo virulence factors. Can J Microbiol 1979, 25: 593-9.
37. Cicmanec, J.F., Holder, I.A. Growth of Pseudomonas aeruginosa in normal and burned skin extract: Role of extracellular proteases. Infect Immun 1979, 25: 477-83.
38. Woods, D.E., Straus, D.C. Jr., Johansson, W.G.R., Bass, J.A. Role of salivary protease activity 'in adherence of Gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest 1981, 68: 1435-40.
39. Döring, G., Dauner, H.-M. Clearance of Pseudomonas aeruginosa in different rat lung infection models. Am Rev Respir Dis 1988, 138: 1249-53.
40. Hamdaoui, A., Wund-Bisseret, F., Bieth, J.G. Fast solubilization of human lung elastin by Pseudomonas aeruginosa elastase. Am Rev Respir Dis 1987, 135: 860-3.
41. Morihara, K., Tsuzuki, H., Oka, T., Inoui, H., Ebata, M. Pseudomonas aeruginosa elastase. Isolation crystallization and preliminary characterization. J Biol Chem 1965, 240: 3295-304.
42. Wolz, C., Hellstern, E., Haug, M., Galloway, D.R., Vasil, M.K., Döring, G. Pseudomonas aeruginosa LasB mutant constructed by insertional mutagenesis reveals elastolytic activity due to alkaline proteinase and LasA fragment. Mol Microbiol 1991, 5: 2125-31.
43. Galloway, D.R. Pseudomonas aeruginosa elastase and elastolysis revisited: Recent developments. Mol Microbiol 1991, 5: 2315-21.
44. Peters, J.E., Galloway, D.R. Purification and characterization of an active fragment of the LasA protein from Pseudomonas aeruginosa: Enhancement of elastase activity. J Bacteriol 1990, 172: 2236-49.
45. Kaur, M., Gupta, M., Tripathi, K.K., Gupta, K.G. Lytic effect of Pseudomonas aeruginosa elastase on Gram-positive and -negative bacteria. Zbl Bakt 1989, 271: 153-7.
46. Machan, Z.A., Pitt, T.L., White, W. et al. Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: Description of an antistaphylococcal substance. J Med Microbiol 1991, 34: 213-7.
47. Sommerville, M., Richardson, P.S., Rutman, A., Wilson, R., Cole, P.J. Stimulation of secretion into human and feline airways by Pseudomonas aeruginosa proteases. J Appl Physiol 1991, 70: 2259-67.
48. Döring, G., Pfestorf, M., Botzenhart, K., Abdallah, M. Impact of proteases on iron uptake of Pseudomonas aeruginosa pyoverdin from transferrin and lactoferrin. Infect Immun 1988, 56: 291-3.
49. Wolz, C., Hohloch, K., Acaktan, A. et al. Iron release from transferrin by pyoverdin and elastase from Pseudomonas aeruginosa. Infect Immun 1994, 62: 4021-7.
50. Britigan, B.E., Edeker, B.L. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J Clin Invest 1991, 88: 1092-102.
51. Döring, G., Dalhoff, A., Vogel, O., Brunner, H., Droge, U., Botzenhart, K. In vivo activity of proteases of Pseudomonas aeruginosa in a rat model. J Infect Dis 1984, 149: 532-7.
52. Döring, G., Obernesser, H.J., Botzenhart, K. Extracellular toxins of P. aeruginosa. II. Effect of two proteases on human IgG, IgA and secretory IgA. Zbl Bakt Mikrobiol Hyg 1 Abt Orig A 1981, 249: 89-98.
53. Schultz, D.R., Miller, K.D. Elastase of Pseudomonas aeruginosa: Inactivation of complement components and complement-derived chemotactic and phagocytic factors. Infect Immun 1974, 10: 128-35.
54. Hong, Y.Q., Ghebrehiwet, B. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin Immunol Immunopathol 1992, 62: 133-8.
55. Kharazmi, A., Nielsen, H. Inhibition of human monocyte chemotaxis and chemiluminescence by Pseudomonas aeruginosa elastase. APMIS 1991, 99: 93-5.
56. Ijiri, Y., Matsumoto, K., Kamata, R., Nishino, N., Okamura, R., Kambara, T., Yamamoto, T. Suppression of polymorphonuclear leucocyte chemotaxis by Pseudomonas aeruginosa elastase in vitro: A study of the mechanisms and the correlation with ring abscess in pseudomonal keratitis. Int J Exp Pathol 1994, 75: 441-51.
57. Berger, M., Sorensen, R.U., Tosi, M.F., Dearborn, D.G., Döring, G. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest 1989, 84: 1302-13.
58. Jacquot, J., Tournier, J.-M., Puchelle, E. In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase but not by human leukocyte elastase. Infect Immun 1985, 47: 555-60.
59. Horvat, R.T., Parmely, M.J. Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity. Infect Immun 1988, 56: 2925-32.
60. 1-proteinase inhibitor. Infect Immun 1979, 24: 188-93.
61. Johnson, D.A., Carter-Hamm, B., Dralle, W.M. Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase. Am Rev Respir Dis 1982, 126: 1070-3.
62. 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase. Biochem Biophys Acta 1984, 789: 37-43.
63. Döring, G., Obernesser, H.J., Botzenhart, K., Flehmig, B., Høiby, N., Hofmann, A. Proteases of Pseudomonas aeruginosa in cystic fibrosis. J Infect Dis 1983, 147: 744-50.
64. Steuhl, K.P., Döring, G., Henni, A., Thiel, H.-J., Botzenhart, K. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Invest Ophthalmol Vis Sci 1987, 28: 1559-68.
65. Ohman, D.E., Chakrabarty, A.M. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa or cystic fibrosis origin. Infect Immun 1982, 37: 662-9.
66. Mohr, C.D., Rust, L., Albus, A.M., Iglewski, B.H., Deretic, V. Expression patterns of genes encoding elastase and controlling mucoidy co-ordinate regulation of two virulence factors in Pseudomonas aeruginosa isolates from cystic fibrosis. Mol Microbiol 1990, 4: 2103-10.
67. Woods, D.E., Sokol, P.A., Bryan, L.E. et al. In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement. J Infect Dis 1991, 163: 143-9.
68. Jaffar-Bandjee, M.C., Lazdunski, A., Bally, M., Carrere, J., Chazalette, T.P., Galabert, C. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J Clin Microbiol 1995, 33: 924-9.
69. 1-antitrypsin in cystic fibrosis bronchopulmonary secretions. Pediatr Pulmonol 1989, 7: 12-7.
70. Döring, G., Høiby, N. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun 1983, 42: 197-201.
71. Döring, G., Buhl, V., Høiby, N., Schiøtz, P.O., Botzenhart, K. Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from the sputum of cystic fibrosis patients. Acta Pathol Microbiol [C] 1984, 92: 307-11.
72. Walker, R.I., Willemze, R. Neutrophil kinetics and the regulation of granulopoiesis. Rev Infect Dis 1980, 2: 282-92.
73. Sordelli, D.O., Djafari, M., Garcia, V.E., Fontan, P.A., Döring, G. Age-dependent pulmonary clearance of Pseudomonas aeruginosa in a mouse model: Diminished migration of polymorphonuclear leukocytes to N-formyl-methionylleucyl-phenylalanine. Infect Immun 1992, 60: 1724-7.
74. Lam, J., Chan, R., Lam, K., Costerton, J.W. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980, 28: 546-56.
75. Baltimore, R.S., Christie, C.D.C., Smith, G.J.W. Immunohistopathologic location of Pseudomonas aeruginosa in lungs of patients with cystic fibrosis. Am Rev Respir Dis 1989, 140: 1650-61.
76. Bruce, M.C., Poncz, L., Klinger, J.D., Stern, R.C., Tomashefski, J.F. Jr., Dearborn, D.G. Biochemical and pathological evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis 1985, 132: 529-35.
77. Fick, R.B., Naegel, G.P., Squier, S.U., Wood, R.E., Gee, B.L., Reynolds, H.Y. Proteins of the cystic fibrosis respiratory tract. J Clin Invest 1984, 74: 236-48.
78. Tournier, J.M., Jacquot, J., Puchelle, E., Bieth, J.G. Evidence that Pseudomonas aeruginosa elastase does not inactivate the bronchial inhibitor in the presence of leukocyte elastase. Am Rev Respir Dis 1985, 132: 524-8.
79. Goldstein, W., Döring, G. Lysosomal enzymes and proteinase inhibitors in the sputum of patients with cystic fibrosis. Am Rev Respir Dis 1986, 134: 49-56.
80. Jackson, A.H., Hill, S.L., Afford, S.C., Stockley, R.A. Sputum solphase proteins and elastase activity in patients with cystic fibrosis. Eur J Respir Dis 1984, 65: 114-24.
81. Suter, S., Schaad, U.B., Roux, L., Nydegger, U.E., Waldvogel, F.A. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis 1984, 149: 523-31.
82. Dwenger, A., Schweitzer, G., Regel, G. Bronchoalveolar lavage fluid and plasma proteins, chemiluminescence response and protein contents of polymorphonuclear leukocytes from blood and lavage fluid in traumatized patients. J Clin Chem Clin Biochem 1986, 24: 73-88.
83. Baugh, R.J., Travis, J. Human leukocyte granule elastase: Rapid isolation and characterization. Biochemistry 1976, 15: 836-41.
84. Heck, L.W., Darby, W.L., Hunter, F.A., Bhown, A., Miller, E.J., Bennett, J.C. Isolation, characterization, and amino-terminal amino acid sequence analysis of human neutrophil elastase from normal donors. Anal Biochem 1985, 149: 153-62.
85. Heck, L.W., Rostand, K.S., Hunter, F.A., Bhown, A. Isolation, characterization, and amino-terminal amino acid sequence analysis of human neutrophil cathepsin G from normal donors. Anal Biochem 1986, 158: 217-27.
86. Suter, S., Schaad, U.B., Morgenthaler, J.J., Chevallier, I., Schnebli, H.-P. Fibronectin-cleaving activity in bronchial secretions of patients with cystic fibrosis. J Infect Dis 1988, 158: 89-100.
87. Smallman, L.A., Hill, S.L., Stockley, R.A. Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: A serine proteinase effect. Thorax 1984, 39: 663-7.
88. Plotkowski, M.C., Beck, G., Tournier, J.M., Bernardo-Filho, M., Marques, E.A., Puchelle, E. Adherence of Pseudomonas aeruginosa to respiratory epithelium and the effect of leucocyte elastase. J Med Microbiol 1989, 30: 285-93.
89. Niederman, M.S., Merrill, W.W., Polomski, L.M., Reynolds, H.Y., Gee, J.B.L. Influence of sputum IgA and elastase on tracheal cell bacterial adherence. Am Rev Respir Dis 1986, 133: 255-60.
90. Salata, R.A., Lederman, M.M., Shlaes, D.M. et al. Diagnosis of nosocomial pneumonia in intubated intensive care unit patients. Am Rev Respir Dis 1987, 135: 426-32.
91. Dal Nogare, A.R., Toews, G.B., Pierce, A.K. Increased salivary elastase precedes Gram-negative bacillary colonization in postoperative patients. Am Rev Respir Dis 1987, 135: 671-5.
92. Sommerhoff, C.P., Nadel, J.A., Basbaum, C.B., Caughey, G.H. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest 1990, 85: 682-9.
93. Schuster, A., Fahy, J.V., Ueki, I., Nadel, J.A. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors. Eur Respir J 1995, 8: 10-4.
94. Leslie, R.G.Y., Alexander, M.D. Cytophilic antibodies. Curr Top Microbiol Immunol 1979, 88: 26-104.
95. Reynolds, H.Y. Pulmonary host defenses in rabbits after immunization with Pseudomonas antigen: Interaction of bacteria, antibodies, macrophages and lymphocytes. J Infect Dis Suppl 1974, 130: 134-42.
96. Döring, G., Goldstein, W., Botzenhart, K. et al. Elastase from polymorphonuclear leucocytes -A regulatory enzyme in immune complex disease. Clin Exp Immunol 1986, 64: 597-605.
97. Suter, S., Schaad, U.B., Roux, L., Nydegger, U.E., Waldvogel, F.A. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis 1984, 149: 523-31.
98. Orr, F.W., Varani, J., Kreutzer, D.L., Senior, R.M., Ward, P.A. Digestion of the fifth component of complement by leukocyte enzymes. Am J Pathol 1979, 94: 75-84.
99. Tosi, M.F., Zakem, H., Berger, M. Neutrophil elastase cleaves C3bi on opsonized Pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 1990, 86: 300-8.
100. Hakansson, H., Venge, P. Kinetic studies on neutrophil phagocytosis. V. Studies on the cooperation between the Fc and C3b receptors. Immunology 1982, 47: 687-94.
101. Carlo, R., Spitznagel, J.K., Studer, E.J., Conrad, D.N., Ruddy, S. Cleavage of membrane bound C3bi, an intermediate on the third component of complement to C3c and C3d-like fragments by crude leucocyte elastase. Immunology 1981, 44: 381-91.
102. Döring, G., Frank, F., Boudier, C., Herbert, S., Fleischer, B., Bellon, G. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J Immunol 1995, 154: 4842-50.
103. Sayre, P.H., Chang, H.C., Hussey, R.E. et al. Molecular cloning and expression of T11 cDNAs reveal a receptor-like structure on human T lymphocytes. Proc Natl Acad Sci USA 1987, 84: 2941.
104. Fitch, F.W. T cell clones and T cell receptors. Microbiol Rev 1986, 50: 50.
105. Desrochers, P.E., Jeffrey, J.J., Weiss, S.J. Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity. J Clin Invest 1991, 87: 2258-65.
106. Welgus, H.G., Campbell, E.J., Cury, J.D. et al. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation and expression during cellular development. J Clin Invest 1990, 86: 1496-502.
107. 1-antitrypsin by metalloproteinases released from neutrophils. J Clin Invest 1988, 82: 706-11.
108. Kao, R.C., Wehner, N.G., Skubitz, K.M., Gray, B.H., Hoidal, J.R. Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest 1988, 82: 1963-73.
109. Reilly, J.J. Jr., Chen, P., Sailor, L.Z., Mason, R.W., Chapman, H.A. Jr. Uptake of extracellular enzyme by a novel pathway is a major determinant of cathepsin L levels in human macrophages. J Clin Invest 1990, 86: 176-83.
110. Sommerhoff, C.P., Caughey, G.H., Finkbeiner, W.E., Lazarus, S.C., Basbaum, C.B., Nadel, J.A. Mast cell chymase. A potent secretagogue for airway gland serous cells. J Immunol 1989, 142: 2450-6.
111. Hart, D.A., Woods, D.E. Urokinase enhances the growth of Pseudomonas spp. in vitro under nonshaking (oxygen limited) conditions. Can J Microbiol 1994, 40: 292-7.
112. Cantin, A.M., Lafrenaye, S., Bégin, R.O. Anti-neutrophil elastase activity in cystic fibrosis serum. Pediatr Pulmonol 1991, 11: 249-53.
113. 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis. Eur Respir J 1991, 4: 40-9.
114. Vogelmeier, C., Hubbard, R.C., Fells, G.A. et al. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest 1991, 87: 482-8.
115. 1-antitrypsin treatment for cystic fibrosis. Lancet 1991, 337: 392-4.
116. McElvaney, N.G., Doujaiji, B., Moan, M.J., Burnham, M.R., Wu, M.C., Crystal, R.G. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis. Am Rev Respir Dis 1993, 148: 1056-60.
117. Kueppers, F., Fiel, S.B. Proteolytic activity of purulent secretions in patients with CF and bronchitis is increased by DNase. Am Rev Respir Dis 1992, 145: A563.
118. Vogelmeier, C., Döring, G. Neutrophil elastase, cathepsin G and rhDNase therapy in cystic fibrosis. Eur Respir J 1996, 9: 2193-5.
119. Döring, G., Knight, R., Bellon, G. Immunology of cystic fibrosis. In: Cystic Fibrosis. Hodson, M.E., Geddes, D. (Eds.). Chapman and Hall: London 1995, 99-130.